Supreme Court Refuses Inter Partes Review

Akorn’s Win On Difluprednate Patent Will Not Be Reopened

 
• By Aidan Fry
  
Supreme_Court
The US Supreme Court has decided not to review inter partes obviousness standards • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin